<\/p>\n
Tenoric<\/strong> \u03b5\u03af\u03bd\u03b1\u03b9 25\/25 mg, 50\/25 mg, 100\/25 mg fixed-dose tablet<\/strong> \u03c0\u03bf\u03c5 \u03c3\u03c5\u03bd\u03b4\u03c5\u03ac\u03b6\u03b5\u03b9 \u03b1\u03c4\u03b5\u03bd\u03bf\u03bb\u03cc\u03bb\u03b7<\/strong> (cardioselective beta-1 blocker) and chlorthalidone<\/strong> (long-acting thiazide-like diuretic) from Ipca Laboratories. Historical combination for hypertension — effective for BP but largely superseded by ACEi\/ARB-based regimens following LIFE and ASCOT which showed atenolol-based therapy inferior to losartan-based and amlodipine-based regimens for stroke prevention and new-onset diabetes. Retains a role in patients already stable on both components, or where angina or rate-control needs make a beta-blocker rational. Typical dosing: one tablet once daily. Contraindications: second\/third-degree AV block, severe asthma, anuria, symptomatic bradycardia, severe hypokalaemia, lithium co-therapy (caution). Monitor BP, HR, potassium, glucose.<\/p>\n<\/div>\n \ud83d\udce6 \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03b3\u03b3\u03cd\u03b7\u03c3\u03b7\u03c2 \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2<\/strong><\/a> \u2014 \u03b5\u03ac\u03bd \u03c4\u03bf \u03b4\u03ad\u03bc\u03b1 \u03c3\u03b1\u03c2 \u03b4\u03b5\u03bd \u03c6\u03c4\u03ac\u03c3\u03b5\u03b9 \u03b5\u03bd\u03c4\u03cc\u03c2 20 \u03b5\u03c1\u03b3\u03ac\u03c3\u03b9\u03bc\u03c9\u03bd \u03b7\u03bc\u03b5\u03c1\u03ce\u03bd, \u03c4\u03bf \u03b5\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03c5\u03bc\u03b5.<\/p>\n \u03a4\u03b1 \u03b3\u03b5\u03bd\u03cc\u03c3\u03b7\u03bc\u03b1 \u03c6\u03ac\u03c1\u03bc\u03b1\u03ba\u03ac \u03bc\u03b1\u03c2 \u03c0\u03c1\u03bf\u03ad\u03c1\u03c7\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03ba\u03b1\u03c4\u03b1\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03c4\u03ad\u03c2 \u03c0\u03bf\u03c5 \u03c0\u03b9\u03c3\u03c4\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd WHO-GMP \u03ba\u03b1\u03b9 \u03b1\u03c0\u03bf\u03c3\u03c4\u03ad\u03bb\u03bb\u03bf\u03bd\u03c4\u03b1\u03b9 \u03c0\u03b1\u03b3\u03ba\u03bf\u03c3\u03bc\u03af\u03c9\u03c2 \u03c3\u03b5 \u03b4\u03b9\u03b1\u03ba\u03c1\u03b9\u03c4\u03b9\u03ba\u03ae, \u03b1\u03c0\u03bb\u03ae \u03c3\u03c5\u03c3\u03ba\u03b5\u03c5\u03b1\u03c3\u03af\u03b1 \u2014 \u03c7\u03c9\u03c1\u03af\u03c2 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5 \u03c3\u03c4\u03bf \u03b5\u03be\u03c9\u03c4\u03b5\u03c1\u03b9\u03ba\u03cc \u03c4\u03bf\u03c5 \u03b4\u03ad\u03bc\u03b1\u03c4\u03bf\u03c2. \u039f\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u03b4\u03c1\u03bf\u03bc\u03bf\u03bb\u03bf\u03b3\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03bc\u03ad\u03c3\u03c9 \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf\u03c5 \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae (\u03bf\u03b9 \u03c0\u03b5\u03c1\u03b9\u03b3\u03c1\u03b1\u03c6\u03ad\u03c2 \u03b5\u03ba\u03ba\u03b1\u03b8\u03ac\u03c1\u03b9\u03c3\u03b7\u03c2 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03bf\u03c5\u03bd \u03c1\u03c5\u03b8\u03bc\u03b9\u03c3\u03bc\u03ad\u03bd\u03bf \u03b5\u03c0\u03b5\u03be\u03b5\u03c1\u03b3\u03b1\u03c3\u03c4\u03ae \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ce\u03bd \u03bc\u03b5 \u03ba\u03ac\u03c1\u03c4\u03b1 \u2014 \u03c0\u03bf\u03c4\u03ad \u201cMedsBase\u201d \u03ae \u03bf\u03c0\u03bf\u03b9\u03bf\u03b4\u03ae\u03c0\u03bf\u03c4\u03b5 \u03cc\u03bd\u03bf\u03bc\u03b1 \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03bf\u03c5). \u0393\u03af\u03bd\u03bf\u03bd\u03c4\u03b1\u03b9 \u03b4\u03b5\u03ba\u03c4\u03ad\u03c2 \u03ba\u03b1\u03b9 \u03c0\u03bb\u03b7\u03c1\u03c9\u03bc\u03ad\u03c2 \u03bc\u03b5 \u03ba\u03c1\u03c5\u03c0\u03c4\u03bf\u03bd\u03bf\u03bc\u03af\u03c3\u03bc\u03b1\u03c4\u03b1 \u03ba\u03b1\u03b9 \u03c4\u03c1\u03b1\u03c0\u03b5\u03b6\u03b9\u03ba\u03ae \u03bc\u03b5\u03c4\u03b1\u03c6\u03bf\u03c1\u03ac SEPA. \u039a\u03ac\u03b8\u03b5 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03bb\u03af\u03b1 \u03ba\u03b1\u03bb\u03cd\u03c0\u03c4\u03b5\u03c4\u03b1\u03b9 \u03b1\u03c0\u03cc \u03c4\u03b7\u03bd \u03a0\u03bf\u03bb\u03b9\u03c4\u03b9\u03ba\u03ae \u0395\u03c0\u03b1\u03bd\u03b1\u03c0\u03bf\u03c3\u03c4\u03bf\u03bb\u03ae\u03c2 \u0395\u03be\u03b1\u03c3\u03c6\u03b1\u03bb\u03af\u03c3\u03b5\u03ce\u03c2 \u03bc\u03b1\u03c2.<\/p>\n Tenoric is a fixed-dose combination tablet of \u03b1\u03c4\u03b5\u03bd\u03bf\u03bb\u03cc\u03bb\u03b7<\/strong> (25-100 mg) and chlorthalidone<\/strong> (typically 25 mg) in a single pill, from Ipca Laboratories. Supplied in 30-90 tablets.<\/p>\n Atenolol was introduced by ICI in 1976 as Tenormin — a cardioselective beta-1 adrenergic blocker. Chlorthalidone is a long-acting thiazide-like diuretic introduced in 1960 and validated as first-line antihypertensive therapy in ALLHAT (2002). The fixed combination (Tenoric, Tenoretic globally) has been on formularies since the 1970s.<\/p>\n \u03a3\u03cd\u03b3\u03c7\u03c1\u03bf\u03bd\u03b7 \u03c4\u03bf\u03c0\u03bf\u03b8\u03ad\u03c4\u03b7\u03c3\u03b7:<\/strong> LIFE (2002), ASCOT (2005), and the INVEST (2003) trials pushed beta-blockers to second-line for uncomplicated hypertension, especially atenolol with chlorthalidone because of new-onset diabetes and inferior stroke prevention vs ARB and CCB regimens. Tenoric retains a place where beta-blockade is rational (concurrent angina, atrial fibrillation rate control, post-MI, resting tachycardia) and a diuretic is still needed.<\/p>\n \u03a4\u03c5\u03c0\u03b9\u03ba\u03ae \u03b4\u03cc\u03c3\u03b7:<\/strong> one 25\/25 mg, 50\/25 mg, 100\/25 mg tablet once daily in the morning (chlorthalidone diuresis can disrupt sleep if dosed at night).<\/p>\n \u03a0\u03c1\u03bf\u03c3\u03b1\u03c1\u03bc\u03bf\u03b3\u03ae \u03b4\u03cc\u03c3\u03b7\u03c2:<\/strong> higher-strength FDCs exist (e.g. 100\/25 mg); for uncontrolled BP, often better to add an ACEi\/ARB or CCB than to further raise atenolol or chlorthalidone.<\/p>\n \u03a0\u03b1\u03c1\u03b1\u03ba\u03bf\u03bb\u03bf\u03cd\u03b8\u03b7\u03c3\u03b7:<\/strong> baseline BP, HR, U&E (potassium, sodium), creatinine, fasting glucose, urate, ECG if bradycardia\/AV concern. Repeat U&E at 1-2 weeks, then at 4-6 weeks. Annual metabolic panel. Watch for hypokalaemia, new gout, worsening diabetic control, symptomatic bradycardia.<\/p>\n Combines profiles of both components. Common:<\/p>\n Uncommon but serious: severe hyponatraemia, symptomatic bradycardia\/AV block, decompensated HF, severe bronchospasm, pancreatitis (thiazide), Stevens-Johnson syndrome.<\/p>\n Store Tenoric below 25°C. Keep out of reach of children.<\/p>\n No — modern guidelines reserve beta-blocker-based regimens as second or third-line for uncomplicated hypertension, largely because of LIFE, ASCOT, and INVEST data showing inferior stroke prevention and increased new-onset diabetes vs ARB and CCB regimens. Tenoric retains a role where beta-blockade is specifically indicated (angina, AF rate control, post-MI).<\/p>\n No — the atenolol component can rebound (tachycardia, BP surge, angina in CAD patients) if stopped abruptly. Taper over 1-2 weeks.<\/p>\n Sometimes. Chlorthalidone can drive potassium below 3.5 mmol\/L; atenolol slightly raises potassium, partially offsetting. Check at baseline, 1-2 weeks, then periodically. Hypokalaemia is usually corrected by adding an ACEi\/ARB (blunts thiazide-induced K loss) rather than potassium supplements.<\/p>\n No — atenolol is linked with fetal growth restriction; thiazides in pregnancy can cause neonatal jaundice and thrombocytopenia. Switch to methyldopa, labetalol, or nifedipine.<\/p>\n You can buy Tenoric (atenolol + chlorthalidone 25\/25 mg, 50\/25 mg, 100\/25 mg, 30-90 tablets) from MedsBase with discreet packaging and worldwide shipping.<\/p>\n <\/p>\n Tenoric is Ipca Laboratories’ fixed-dose atenolol (25\/50\/100 mg) + chlorthalidone 25 mg tablets \u2014 beta-blocker + thiazide-like diuretic combination. Historical first-line combo for hypertension (Tenoretic globally, 1970s). Modern guidelines push beta-blocker-based regimens to second-line for uncomplicated HTN (LIFE\/ASCOT data) \u2014 retained role for HTN with angina, AF rate control, post-MI. Monitor potassium and glucose. Never stop abruptly.<\/p>","protected":false},"featured_media":52015,"comment_status":"open","ping_status":"open","template":"","meta":[],"product_brand":[],"product_cat":[3141,3223,3260,3356],"product_tag":[3365,3441],"class_list":{"0":"post-52014","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-category-overview","7":"product_cat-chronic-conditions","8":"product_cat-heart-blood-pressure","9":"product_cat-high-blood-pressure-medication","10":"product_tag-atenolol","11":"product_tag-chlorthalidone","13":"first","14":"outofstock","15":"shipping-taxable","16":"purchasable","17":"product-type-variable","18":"has-default-attributes"},"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product\/52014","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/comments?post=52014"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media\/52015"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/media?parent=52014"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_brand?post=52014"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_cat?post=52014"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/el\/wp-json\/wp\/v2\/product_tag?post=52014"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}\u0393\u03b9\u03b1\u03c4\u03af \u03bd\u03b1 \u03c0\u03b1\u03c1\u03b1\u03b3\u03b3\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03b1\u03c0\u03cc \u03c4\u03b7 MedsBase<\/h3>\n
What Is Tenoric?<\/h2>\n
Why Combine a Beta-Blocker With a Thiazide?<\/h2>\n
\n
\u0394\u03bf\u03c3\u03bf\u03bb\u03bf\u03b3\u03af\u03b1<\/h2>\n
\u03a0\u03b1\u03c1\u03b5\u03bd\u03ad\u03c1\u03b3\u03b5\u03b9\u03b5\u03c2<\/h2>\n
\n
\u0391\u03bd\u03c4\u03b5\u03bd\u03b4\u03b5\u03af\u03be\u03b5\u03b9\u03c2<\/h2>\n
\n
\u0391\u03bb\u03bb\u03b7\u03bb\u03b5\u03c0\u03b9\u03b4\u03c1\u03ac\u03c3\u03b5\u03b9\u03c2 \u03a6\u03b1\u03c1\u03bc\u03ac\u03ba\u03c9\u03bd<\/h2>\n
\n
\u0391\u03c0\u03bf\u03b8\u03ae\u03ba\u03b5\u03c5\u03c3\u03b7<\/h2>\n
\u03a3\u03c5\u03c7\u03bd\u03ad\u03c2 \u0395\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2<\/h2>\n
Is Tenoric a first-line BP drug today?<\/h3>\n
Can I stop Tenoric abruptly?<\/h3>\n
Will I need potassium on Tenoric?<\/h3>\n
Can I take Tenoric in pregnancy?<\/h3>\n
Where can I buy Tenoric online?<\/h3>\n
\u03a3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ac \u039a\u03b1\u03c1\u03b4\u03b9\u03b1\u03ba\u03ac & \u03a5\u03c0\u03b5\u03c1\u03c4\u03b1\u03c3\u03b9\u03ba\u03ac \u03a6\u03ac\u03c1\u03bc\u03b1\u03ba\u03b1<\/h2>\n
\n